Figure 6
Figure 6. Knockdown of XBP1 in BMSCs compromises BMSC secretion of RANKL and support of OCL formation. (A) Western blot demonstrating the effects of XBP1 knockdown on the baseline and TNFα-induced sRANKL protein levels in the total lysates of the BMSCs of both healthy donors (n = 3; left) and MM patients (n = 4; right). β-actin served as the loading control. (B) Schematic quantitative representation of results shown in panel A. The sRANKL protein levels were normalized to those of β-actin. The baseline relative sRANKL protein levels of the healthy donor BMSCs in the absence of hXbp1 shRNAs are arbitrarily defined as 1. Error bars represent means ± SD. (C) Effect of XBP1 knockdown on the capacity of MM patient BMSCs to support OCL formation (n = 3; mean ± SD; *P < .05).

Knockdown of XBP1 in BMSCs compromises BMSC secretion of RANKL and support of OCL formation. (A) Western blot demonstrating the effects of XBP1 knockdown on the baseline and TNFα-induced sRANKL protein levels in the total lysates of the BMSCs of both healthy donors (n = 3; left) and MM patients (n = 4; right). β-actin served as the loading control. (B) Schematic quantitative representation of results shown in panel A. The sRANKL protein levels were normalized to those of β-actin. The baseline relative sRANKL protein levels of the healthy donor BMSCs in the absence of hXbp1 shRNAs are arbitrarily defined as 1. Error bars represent means ± SD. (C) Effect of XBP1 knockdown on the capacity of MM patient BMSCs to support OCL formation (n = 3; mean ± SD; *P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal